Stay updated on AXS-05 in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the AXS-05 in Alzheimer's Agitation Clinical Trial page.

Latest updates to the AXS-05 in Alzheimer's Agitation Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 across the page; this is a minor version update and does not change content or user-facing features.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision: v3.4.3 added and v3.4.2 removed.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page now displays Revision: v3.4.2 and the government funding notice has been removed; these are administrative updates that do not change study content or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check60 days agoChange DetectedAdded a government funding notice about potential information delays and that the NIH Clinical Center is open with guidance to opm.gov; updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check67 days agoChange DetectedThe page adds a glossary toggle and displays new update-related metadata (Last Update Submitted that Met QC Criteria, Last Update Posted) along with a revision indicator (Revision: v3.4.0), while removing older timestamp elements (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4. No other study details content appears to have changed.SummaryDifference0.0%

Stay in the know with updates to AXS-05 in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXS-05 in Alzheimer's Agitation Clinical Trial page.